National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

levonantradol
A synthetic cannabinoid analogue of delta (9)-tetrahydrocannabinol (delta(9)-THC) with antiemetic and anti-analgesic properties. Although its precise mechanism of action is unknown, levonantradol appears to bind and activate the cannabinoid receptors CB1 and/or CB2. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Levonantradol HCl



Previous:Levaquin, levetiracetam, levocarnitine, levodopa, levofloxacin
Next:levonorgestrel, levonorgestrel-releasing intrauterine system, Levopa, levothyroxine sodium, Levoxyl

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov